These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents. Darrow JJ; Beall RF; Kesselheim AS Appl Health Econ Health Policy; 2019 Feb; 17(1):47-54. PubMed ID: 30141133 [TBL] [Abstract][Full Text] [Related]
6. The new follow-on-biologics law: a section by section analysis of the patent litigation provisions in the Biologics Price Competition and Innovation Act of 2009. Dougherty MP Food Drug Law J; 2010; 65(2):231-45, i. PubMed ID: 24475541 [TBL] [Abstract][Full Text] [Related]
7. Biotech reels over patent ruling. Check-Hayden E Nature; 2014 Jul; 511(7508):138. PubMed ID: 25008505 [No Abstract] [Full Text] [Related]
9. Strange Bedfellows: Native American Tribes, Big Pharma, and the Legitimacy of Their Alliance. Kennedy DC Duke Law J; 2019 Apr; 68(7):1433-68. PubMed ID: 30995705 [TBL] [Abstract][Full Text] [Related]
10. An Administrative Meter Maid: Using Inter Partes Review and Post-Grant Review to Curb Exclusivity Parking via the "Failure to Market" Provision of the Hatch-Waxman Act. Apel BT Mich Law Rev; 2015; 114(1):107-36. PubMed ID: 26394458 [TBL] [Abstract][Full Text] [Related]
11. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape. Lu DL; Kowalski TJ; Jarecki-Black J Future Med Chem; 2010 Jan; 2(1):7-9. PubMed ID: 21426040 [No Abstract] [Full Text] [Related]
13. Striking the right balance between innovation and drug price competition: putting the Hatch-Waxman Act into perspective. Deal JB Food Drug Law J; 1999; 54(2):185-6. PubMed ID: 11759712 [No Abstract] [Full Text] [Related]
14. The market for follow-on biologics: how will it evolve? Grabowski H; Cockburn I; Long G Health Aff (Millwood); 2006; 25(5):1291-301. PubMed ID: 16966725 [TBL] [Abstract][Full Text] [Related]
16. Striking the right balance between innovation and drug price competition: understanding the Hatch-Waxman Act--an introduction of speakers. Rea TS Food Drug Law J; 1999; 54(2):223-5. PubMed ID: 11759713 [No Abstract] [Full Text] [Related]
17. Patent fight sparks biological warfare in the drug industry. Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662 [No Abstract] [Full Text] [Related]
18. Pharmaceutical patent challenges--time for reassessment? Glass G Nat Rev Drug Discov; 2004 Dec; 3(12):1057-62. PubMed ID: 15573104 [TBL] [Abstract][Full Text] [Related]
19. Court upholds infringement of research tool patents, but discounts damages. Maebius SB; Warburg RJ Pharmacogenomics; 2003 Jul; 4(4):369-70. PubMed ID: 12831314 [No Abstract] [Full Text] [Related]